Physical Therapy Market Size, Share, and Trends 2025 to 2034

The global physical therapy market size is calculated at USD 26.04 billion in 2025 and is forecasted to reach around USD 49.18 billion by 2034, accelerating at a CAGR of 7.32% from 2025 to 2034. The North America market size surpassed USD 9.71 billion in 2024 and is expanding at a CAGR of 7.45% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : June 2025  |  Report Code : 6282  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Physical Therapy Market 

5.1. COVID-19 Landscape: Physical Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Physical Therapy Market, By Application

8.1. Physical Therapy Market, by Application

8.1.1. Orthopedic Physical Therapy

8.1.1.1. Market Revenue and Forecast

8.1.2. Geriatric Physical Therapy

8.1.2.1. Market Revenue and Forecast

8.1.3. Neurological Physical Therapy

8.1.3.1. Market Revenue and Forecast

8.1.4. Cardiopulmonary and Pulmonary Physical Therapy

8.1.4.1. Market Revenue and Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Physical Therapy Market, By Age Group

9.1. Physical Therapy Market, by Age Group

9.1.1. Pediatrics

9.1.1.1. Market Revenue and Forecast

9.1.2. Adults

9.1.2.1. Market Revenue and Forecast

9.1.3. Elderly

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Physical Therapy Market, By End-User 

10.1. Physical Therapy Market, by End-User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast

10.1.2. Private Practices

10.1.2.1. Market Revenue and Forecast

10.1.3. Outpatient Clinics

10.1.3.1. Market Revenue and Forecast

10.1.4. Sports and Fitness Facility Centers

10.1.4.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Physical Therapy Market, By Treatment Procedure 

11.1. Physical Therapy Market, by Treatment Procedure

11.1.1. Equipment

11.1.1.1. Market Revenue and Forecast

11.1.2. Therapies           

11.1.2.1. Market Revenue and Forecast

11.1.3. Products

Chapter 12. Global Physical Therapy Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Application

12.1.2. Market Revenue and Forecast, by Age Group

12.1.3. Market Revenue and Forecast, by End-User

12.1.4. Market Revenue and Forecast, by Treatment Procedure

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Application

12.1.5.2. Market Revenue and Forecast, by Age Group

12.1.5.3. Market Revenue and Forecast, by End-User

12.1.5.4. Market Revenue and Forecast, by Treatment Procedure

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Application

12.1.6.2. Market Revenue and Forecast, by Age Group

12.1.6.3. Market Revenue and Forecast, by End-User

12.1.6.4. Market Revenue and Forecast, by Treatment Procedure

12.2. Europe

12.2.1. Market Revenue and Forecast, by Application

12.2.2. Market Revenue and Forecast, by Age Group

12.2.3. Market Revenue and Forecast, by End-User

12.2.4. Market Revenue and Forecast, by Treatment Procedure

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Application

12.2.5.2. Market Revenue and Forecast, by Age Group

12.2.5.3. Market Revenue and Forecast, by End-User

12.2.5.4. Market Revenue and Forecast, by Treatment Procedure

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Application

12.2.6.2. Market Revenue and Forecast, by Age Group

12.2.6.3. Market Revenue and Forecast, by End-User

12.2.6.4. Market Revenue and Forecast, by Treatment Procedure

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Application

12.2.7.2. Market Revenue and Forecast, by Age Group

12.2.7.3. Market Revenue and Forecast, by End-User

12.2.7.4. Market Revenue and Forecast, by Treatment Procedure

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Application

12.2.8.2. Market Revenue and Forecast, by Age Group

12.2.8.3. Market Revenue and Forecast, by End-User

12.2.8.4. Market Revenue and Forecast, by Treatment Procedure

12.3. APAC

12.3.1. Market Revenue and Forecast, by Application

12.3.2. Market Revenue and Forecast, by Age Group

12.3.3. Market Revenue and Forecast, by End-User

12.3.4. Market Revenue and Forecast, by Treatment Procedure

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Application

12.3.5.2. Market Revenue and Forecast, by Age Group

12.3.5.3. Market Revenue and Forecast, by End-User

12.3.5.4. Market Revenue and Forecast, by Treatment Procedure

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Application

12.3.6.2. Market Revenue and Forecast, by Age Group

12.3.6.3. Market Revenue and Forecast, by End-User

12.3.6.4. Market Revenue and Forecast, by Treatment Procedure

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Application

12.3.7.2. Market Revenue and Forecast, by Age Group

12.3.7.3. Market Revenue and Forecast, by End-User

12.3.7.4. Market Revenue and Forecast, by Treatment Procedure

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Application

12.3.8.2. Market Revenue and Forecast, by Age Group

12.3.8.3. Market Revenue and Forecast, by End-User

12.3.8.4. Market Revenue and Forecast, by Treatment Procedure

12.4. MEA

12.4.1. Market Revenue and Forecast, by Application

12.4.2. Market Revenue and Forecast, by Age Group

12.4.3. Market Revenue and Forecast, by End-User

12.4.4. Market Revenue and Forecast, by Treatment Procedure

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Application

12.4.5.2. Market Revenue and Forecast, by Age Group

12.4.5.3. Market Revenue and Forecast, by End-User

12.4.5.4. Market Revenue and Forecast, by Treatment Procedure

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Application

12.4.6.2. Market Revenue and Forecast, by Age Group

12.4.6.3. Market Revenue and Forecast, by End-User

12.4.6.4. Market Revenue and Forecast, by Treatment Procedure

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Application

12.4.7.2. Market Revenue and Forecast, by Age Group

12.4.7.3. Market Revenue and Forecast, by End-User

12.4.7.4. Market Revenue and Forecast, by Treatment Procedure

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Application

12.4.8.2. Market Revenue and Forecast, by Age Group

12.4.8.3. Market Revenue and Forecast, by End-User

12.4.8.4. Market Revenue and Forecast, by Treatment Procedure

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Application

12.5.2. Market Revenue and Forecast, by Age Group

12.5.3. Market Revenue and Forecast, by End-User

12.5.4. Market Revenue and Forecast, by Treatment Procedure

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Application

12.5.5.2. Market Revenue and Forecast, by Age Group

12.5.5.3. Market Revenue and Forecast, by End-User

12.5.5.4. Market Revenue and Forecast, by Treatment Procedure

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Application

12.5.6.2. Market Revenue and Forecast, by Age Group

12.5.6.3. Market Revenue and Forecast, by End-User

12.5.6.4. Market Revenue and Forecast, by Treatment Procedure

Chapter 13. Company Profiles

13.1. AmeriCare Physical Therapy (U.S.)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Rehab Alternatives PLLC (U.S.)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. PIVOT Physical Therapy (U.S.)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. ProHealth Limited (Hong Kong)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Abb BTL (India)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. DJO LLC (U.S.)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Performance Health (U.S.)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Athletico Physical Therapy (U.S.)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Abb Geisinger Health (U.S.)ott

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Select Medical Corporation (U.S.)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global physical therapy market is expected to increase from USD 24.27 billion in 2024 to USD 49.18 billion by 2034.

The physical therapy market is expected to grow at a compound annual growth rate (CAGR) of around 7.32% from 2025 to 2034.

The major players in the physical therapy market include AmeriCare Physical Therapy (U.S.), Rehab Alternatives PLLC (U.S.), PIVOT Physical Therapy (U.S.), ProHealth Limited (Hong Kong), BTL (India), DJO LLC (U.S.), Performance Health (U.S.), Athletico Physical Therapy (U.S.), Geisinger Health (U.S.), Select Medical Corporation (U.S.), Knight Health Holdings, LLC (U.S.), Concentra, Inc. (U.S.), EMS Physio Ltd. (U.K.), U.S. Physical Therapy, Inc. (U.S.), and Isokinetics (U.S.).

The driving factors of the physical therapy market are the adoption of outpatient and home-based care models is on the rise, significantly boosting the demand for mobile physical therapy services.

North America region will lead the global physical therapy market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client